Jefferies Group's SLNO Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 29,304 shares of Soleno Therapeutics, Inc. (SLNO) worth $1.36 M, representing 0.01% of the portfolio. First purchased in 2023-Q4, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in SLNO, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 12,004 shares. Largest reduction occurred in Q4 2024, reducing 11,281 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Soleno Therapeutics (SLNO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Soleno Therapeutics (SLNO) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +12,004 | Add 69.39% | 29,304 | $46.30 |
| Q3 2025 | +3,300 | Add 23.57% | 17,300 | $67.60 |
| Q2 2025 | -999 | Reduce 6.66% | 14,000 | $83.78 |
| Q1 2025 | -9,015 | Reduce 37.54% | 14,999 | $71.45 |
| Q4 2024 | -11,281 | Reduce 31.96% | 24,014 | $44.95 |
| Q3 2024 | +204 | Add 0.58% | 35,295 | $50.49 |
| Q2 2024 | -800 | Reduce 2.23% | 35,091 | $40.80 |
| Q1 2024 | +800 | Add 2.28% | 35,891 | $42.80 |
| Q4 2023 | +35,091 | New Buy | 35,091 | $40.25 |
Jefferies Group's Soleno Therapeutics Investment FAQs
Jefferies Group first purchased Soleno Therapeutics, Inc. (SLNO) in Q4 2023, acquiring 35,091 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Soleno Therapeutics, Inc. (SLNO) for 9 quarters since Q4 2023.
Jefferies Group's largest addition to Soleno Therapeutics, Inc. (SLNO) was in Q4 2023, adding 35,091 shares worth $1.41 M.
According to the latest 13F filing for Q4 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 29,304 shares of Soleno Therapeutics, Inc. (SLNO), valued at approximately $1.36 M.
As of the Q4 2025 filing, Soleno Therapeutics, Inc. (SLNO) represents approximately 0.01% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Soleno Therapeutics, Inc. (SLNO) was 35,891 shares, as reported at the end of Q1 2024.